Cellular and molecular aspects of bladder hypertrophy

Area of Science:

• Urology
• Cellular Biology
• Pharmacology

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men, leading to bladder dysfunction.
• Progressive BPH causes irreversible bladder damage through a cycle of hypertrophy, ischemia, and cellular injury.
• Key cellular changes include denervation, mitochondrial dysfunction, and calcium handling abnormalities.

Purpose of the Study:

• To investigate the cellular mechanisms underlying bladder dysfunction in a rabbit model of partial outlet obstruction.
• To evaluate the therapeutic potential of Pygeum africanum extract (Tadenan) in mitigating these cellular changes and functional deficits.

Main Methods:

• A rabbit model of partial outlet obstruction was used to induce bladder dysfunction.
• Cellular changes such as denervation, mitochondrial dysfunction, and calcium disturbances were analyzed.
• Rabbits were pretreated with Pygeum africanum extract (Tadenan) to assess its protective effects.

Main Results:

• Partial outlet obstruction led to progressive denervation, mitochondrial dysfunction, and calcium release disturbances in the bladder.
• These cellular changes are hypothesized to result from ischemia-induced activation of enzymes and free radical generation.
• Pretreatment with Tadenan significantly reduced both contractile and metabolic dysfunctions caused by obstruction.

Conclusions:

• Outlet obstruction triggers cellular damage in the bladder, contributing to BPH-related dysfunction.
• Pygeum africanum extract (Tadenan) demonstrates a protective effect against these cellular insults.
• The bladder is a viable therapeutic target for non-surgical BPH treatments, with Tadenan showing promise.